Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samia Mora

Showing results (81-90 of 260) with videos related to

Pageof 26
Sort By:
European Heart Journal|August 29, 2025
C-reactive protein and cardiovascular risk among women with no standard modifiable risk factors: evaluating the 'SMuRF-less but inflamed'Paul M Ridker, Gemma A Figtree, M Vinayaga Moorthy, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 25, 2015
Novel protein glycan side-chain biomarker and risk of incident type 2 diabetes mellitusAkintunde O Akinkuolie, Aruna D Pradhan, Julie E Buring, et al.
Circulation|May 5, 2010
Exercise blood pressure and future cardiovascular death in asymptomatic individualsSandra A Weiss, Roger S Blumenthal, A Richey Sharrett, et al.
Clinical Chemistry|January 1, 2014
What's different about women's health?Ann M Gronowski, Joann E Manson, Elaine R Mardis, et al.
Journal of the American Heart Association|February 28, 2020
Habitual Fish Consumption, n-3 Fatty Acids, and Nuclear Magnetic Resonance Lipoprotein Subfractions in WomenNuria Amigó, Akintunde O Akinkuolie, Stephanie E Chiuve, et al.
JAMA|July 20, 2007
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in womenSandeep Bansal, Julie E Buring, Nader Rifai, et al.
Metabolism: Clinical and Experimental|October 18, 2020
Fasting status and metabolic health in relation to plasma branched chain amino acid concentrations in womenDeirdre K Tobias, Samia Mora, Subodh Verma, et al.
Circulation|February 24, 2010
Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trialsSamia Mora, Robert J Glynn, Judith Hsia, et al.
Journal of Clinical Lipidology|March 12, 2011
Clinical implications of discordance between low-density lipoprotein cholesterol and particle numberJames D Otvos, Samia Mora, Irina Shalaurova, et al.
Circulation|July 13, 2014
Prognostic value of fasting versus nonfasting low-density lipoprotein cholesterol levels on long-term mortality: insight from the National Health and Nutrition Examination Survey III (NHANES-III)Bethany Doran, Yu Guo, Jinfeng Xu, et al.
Pageof 26

Showing results (81-90 of 260) with videos related to

Sort By:
Pageof 26
European Heart Journal|August 29, 2025
C-reactive protein and cardiovascular risk among women with no standard modifiable risk factors: evaluating the 'SMuRF-less but inflamed'Paul M Ridker, Gemma A Figtree, M Vinayaga Moorthy, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 25, 2015
Novel protein glycan side-chain biomarker and risk of incident type 2 diabetes mellitusAkintunde O Akinkuolie, Aruna D Pradhan, Julie E Buring, et al.
Circulation|May 5, 2010
Exercise blood pressure and future cardiovascular death in asymptomatic individualsSandra A Weiss, Roger S Blumenthal, A Richey Sharrett, et al.
Clinical Chemistry|January 1, 2014
What's different about women's health?Ann M Gronowski, Joann E Manson, Elaine R Mardis, et al.
Journal of the American Heart Association|February 28, 2020
Habitual Fish Consumption, n-3 Fatty Acids, and Nuclear Magnetic Resonance Lipoprotein Subfractions in WomenNuria Amigó, Akintunde O Akinkuolie, Stephanie E Chiuve, et al.
JAMA|July 20, 2007
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in womenSandeep Bansal, Julie E Buring, Nader Rifai, et al.
Metabolism: Clinical and Experimental|October 18, 2020
Fasting status and metabolic health in relation to plasma branched chain amino acid concentrations in womenDeirdre K Tobias, Samia Mora, Subodh Verma, et al.
Circulation|February 24, 2010
Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trialsSamia Mora, Robert J Glynn, Judith Hsia, et al.
Journal of Clinical Lipidology|March 12, 2011
Clinical implications of discordance between low-density lipoprotein cholesterol and particle numberJames D Otvos, Samia Mora, Irina Shalaurova, et al.
Circulation|July 13, 2014
Prognostic value of fasting versus nonfasting low-density lipoprotein cholesterol levels on long-term mortality: insight from the National Health and Nutrition Examination Survey III (NHANES-III)Bethany Doran, Yu Guo, Jinfeng Xu, et al.
Pageof 26